MYD88 and arthritic joint disease: In particular, they underscore the complex and central role of TLR4/MyD88 signalling in regulating the gut-bone marrow axis in musculoskeletal homoeostasis and its dysregulation resulting in systemic inflammation, breaking of tolerance, aberrant osteoclastogenesis and consequently joint destruction in arthritis.